Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth.

George J, Banik NL, Ray SK.

J Cell Mol Med. 2009 Oct;13(10):4205-18. doi: 10.1111/j.1582-4934.2008.00539.x.

2.

Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells.

George J, Banik NL, Ray SK.

Neurochem Res. 2009 Jan;34(1):66-78. doi: 10.1007/s11064-008-9659-z. Epub 2008 Mar 21.

PMID:
18357521
3.

The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.

Le XF, Mao W, He G, Claret FX, Xia W, Ahmed AA, Hung MC, Siddik ZH, Bast RC Jr.

J Natl Cancer Inst. 2011 Sep 21;103(18):1403-22. doi: 10.1093/jnci/djr280. Epub 2011 Aug 2.

4.

Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.

George J, Banik NL, Ray SK.

Neuro Oncol. 2010 Nov;12(11):1088-101. doi: 10.1093/neuonc/noq079. Epub 2010 Aug 2.

5.

Saponin 1 induces apoptosis and suppresses NF-κB-mediated survival signaling in glioblastoma multiforme (GBM).

Li J, Tang H, Zhang Y, Tang C, Li B, Wang Y, Gao Z, Luo P, Yin A, Wang X, Cheng G, Fei Z.

PLoS One. 2013 Nov 21;8(11):e81258. doi: 10.1371/journal.pone.0081258. eCollection 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/0c3019ff-6d7b-444b-8eb5-9461f3dcd029.

6.

Valproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G cells.

Roy Choudhury S, Karmakar S, Banik NL, Ray SK.

Neurochem Res. 2011 Dec;36(12):2292-305. doi: 10.1007/s11064-011-0554-7. Epub 2011 Jul 24.

PMID:
21786169
7.

Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines.

George J, Banik NL, Ray SK.

Int J Biochem Cell Biol. 2010 Jul;42(7):1164-73. doi: 10.1016/j.biocel.2010.04.002. Epub 2010 Apr 13.

9.

PARP inhibition restores extrinsic apoptotic sensitivity in glioblastoma.

Karpel-Massler G, Pareja F, Aimé P, Shu C, Chau L, Westhoff MA, Halatsch ME, Crary JF, Canoll P, Siegelin MD.

PLoS One. 2014 Dec 22;9(12):e114583. doi: 10.1371/journal.pone.0114583. eCollection 2014.

10.

[Inhibitory effects of siRNA targeting epidermal growth factor receptor on proliferation and invasion of human glioblastoma cells].

Kang CS, Pu PY, Wang GX, Li YH, Dong L, Wang H.

Zhonghua Yi Xue Za Zhi. 2004 Sep 17;84(18):1503-8. Chinese.

PMID:
15500708
11.

Knockdown of cyclin D1 inhibits proliferation, induces apoptosis, and attenuates the invasive capacity of human glioblastoma cells.

Wang J, Wang Q, Cui Y, Liu ZY, Zhao W, Wang CL, Dong Y, Hou L, Hu G, Luo C, Chen J, Lu Y.

J Neurooncol. 2012 Feb;106(3):473-84. doi: 10.1007/s11060-011-0692-4. Epub 2011 Sep 13.

PMID:
21912938
12.

siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.

Lei XY, Zhong M, Feng LF, Zhu BY, Tang SS, Liao DF.

Clin Exp Pharmacol Physiol. 2007 May-Jun;34(5-6):450-6.

PMID:
17439414
13.

Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma.

Kargiotis O, Chetty C, Gondi CS, Tsung AJ, Dinh DH, Gujrati M, Lakka SS, Kyritsis AP, Rao JS.

Oncogene. 2008 Aug 14;27(35):4830-40. doi: 10.1038/onc.2008.122. Epub 2008 Apr 28.

14.

A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.

Wu Y, Tang M, Wu Y, Weng X, Yang L, Xu W, Yi W, Gao J, Bode AM, Dong Z, Cao Y.

Cell Oncol (Dordr). 2014 Feb;37(1):53-67. doi: 10.1007/s13402-013-0163-3. Epub 2013 Dec 5.

PMID:
24306928
15.

Adenovirus-mediated delivery of CALR and MAGE-A3 inhibits invasion and angiogenesis of glioblastoma cell line U87.

Liu XL, Zhao D, Sun DP, Wang Y, Li Y, Qiu FQ, Ma P.

J Exp Clin Cancer Res. 2012 Feb 1;31:8. doi: 10.1186/1756-9966-31-8.

16.

Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.

Yang W, Sun T, Cao J, Liu F.

Int J Radiat Biol. 2010 Jun;86(6):445-57. doi: 10.3109/09553001003668006.

PMID:
20470195
17.

Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo.

Zhang K, Zhang S, Jiao X, Wang H, Zhang D, Niu Z, Shen Y, Lv L, Zhou Y.

Med Oncol. 2011 Dec;28(4):1089-100. doi: 10.1007/s12032-010-9652-7. Epub 2010 Aug 21.

PMID:
20730573
18.

Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF.

Wu YY, Chen L, Wang GL, Zhang YX, Zhou JM, He S, Qin J, Zhu YY.

J Mol Histol. 2013 Aug;44(4):433-45. doi: 10.1007/s10735-012-9480-5. Epub 2013 May 1.

PMID:
23636606
19.

Silencing Wnt2B by siRNA interference inhibits metastasis and enhances chemotherapy sensitivity in ovarian cancer.

Wang H, Fan L, Xia X, Rao Y, Ma Q, Yang J, Lu Y, Wang C, Ma D, Huang X.

Int J Gynecol Cancer. 2012 Jun;22(5):755-61. doi: 10.1097/IGC.0b013e3182540284.

PMID:
22635028
20.

Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.

Mu P, Nagahara S, Makita N, Tarumi Y, Kadomatsu K, Takei Y.

Int J Cancer. 2009 Dec 15;125(12):2978-90. doi: 10.1002/ijc.24382.

Supplemental Content

Support Center